Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06961747 · ClinicalTrials.gov registry record · Phase 1
A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women
A Phase 1 study of Healthy Participants, sponsored by UCB Biopharma SRL.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
- 2
- Study locations
NCT06961747 is a Phase 1 study of Healthy Participants that is actively recruiting participants, run by UCB Biopharma SRL. The registered enrollment target is 15 participants, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06961747, a Phase 1 study of Healthy Participants, is actively recruiting participants, sponsored by UCB Biopharma SRL.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to assess the steady state (SS) concentrations of zilucoplan (ZLP) and its major metabolites in mature breast milk of healthy study participants following injection of repeated once-daily doses of ZLP.
Conditions Studied
Interventions
- DRUG Zilucoplan
Study Locations (2)
Texas
- UP0137 2 - San Antonio
Utah
- UP0137 1 - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-07-09 |
| Est. Completion | 2026-07-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06961747
The ClinicalTrials.gov registry entry for NCT06961747 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 66-participant average among 119 other Healthy Participants trials with a reported enrollment target (77% lower). The listed sponsor is UCB Biopharma SRL, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy Participants appearing as the primary indexed condition, and to 1 intervention - of which Zilucoplan is the first listed.
NCT06961747 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Texas, Utah.
Frequently Asked Questions
What is clinical trial NCT06961747 about?
NCT06961747 is a clinical study titled "A Study to Assess Zilucoplan Concentration in Breast Milk of Healthy Lactating Women". The purpose of this study is to assess the steady state (SS) concentrations of zilucoplan (ZLP) and its major metabolites in mature breast milk of healthy study participants following injection of repeated once-daily doses of ZLP.
What is the current status of trial NCT06961747?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2025-07-09. Estimated completion is 2026-07-22.
What conditions does trial NCT06961747 study?
This clinical trial studies the following conditions: Healthy Participants.
What interventions are being tested in trial NCT06961747?
The interventions under investigation include: Zilucoplan (DRUG).
Who is sponsoring clinical trial NCT06961747?
This trial is sponsored by UCB Biopharma SRL, which has 82 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06961747 being conducted?
This trial has 2 study locations across Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Assess the Bioequivalence of Trastuzumab Via Different Subcutaneous Delivery Platforms in Healthy Male Participants
RECRUITING · Phase 1
-
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
RECRUITING · Phase 1
-
A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food
RECRUITING · Phase 1
-
A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants
RECRUITING · Phase 1
-
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
RECRUITING · Phase 1
-
A Study to Learn About a Vaccine Against E Coli in Healthy Adults
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.